WASHINGTON, D.C. (April 19, 2007) -- The issues of providing improved access to innovative treatments and increasing participation of minority communities in the biotechnology industry will be addressed at the 2007 BIO International Convention, running May 6-9, 2007 at the Boston Convention and Exhibition Center in Boston, Massachusetts. The Super Session titled, “Improving Biotechnology Industry Access to Underserved Populations,” will take place Wednesday, May 9, from 9:15 a.m. – 10:45 a.m.
Sponsored by Genentech, this year’s session will continue the dialogue started at the 2005 BIO International Convention regarding the need for all communities to participate actively in all facets of the biotechnology industry. This year’s session will feature industry leaders dedicated to promoting diversity in biotechnology.
“In order for companies engaged in clinical trials to fulfill the promise of conquering life threatening diseases through research, development, manufacturing and commercialization of drugs for unmet medical needs, we must ensure representative participation of all members of the global community,” stated Monica L. Poindexter, associate director, Corporate Diversity at Genentech. “We believe this Super Session will be a great forum for anyone with an interest in expanding their work with the minority and underserved communities.”
The panel will be moderated by Dr. Jonca Bull, Director, Clinical Regulatory Policy, Genentech. Panelists will include Anaclim CEO Dr. Alfonso Alanis; Dr. Peter Carberry, Vice President of Clinical Trials, Genentech; Dr. Armin Weinberg & Dr. Placido Grino, Chronic Disease Prevention and Control Research Center (CDPCRC) Baylor College of Medicine and the Intercultural Cancer Council (ICC); and Emmanuel A. Taylor, MSc., DrPH Health Scientist Administrator Center to Reduce Cancer Health Disparities (CRCHD) National Cancer Institute (NCI)National Institutes of Health (NIH).
This year’s BIO International Convention, themed “New Ideas. Bold Ventures. Global Benefits,” will feature a program packed with more than 200 sessions and speakers focusing on the global aspects of biotechnology, including business development, global health, clinical research/clinical trials, policy, bioethics, devices and diagnostics, biopreparedness, intellectual property/legal, food and agriculture, and industrial and environmental issues. International seminars will spotlight national-level developments from more than 30 countries and regions worldwide. To view the full conference program, please visit www.bio2007.org/Attendees/educational_sessions/index.html.
General registration for the BIO International Convention is now available at www.bio.org/Registration/index.html. For more information about the global event for biotechnology, including housing and program updates, please visit the event homepage at www.bio2007.org.
Advance media registration for the BIO International Convention is now available online. Registration is complimentary for credentialed members of the news media. To register, please visit www.bio2007.org/Media/index.html. Reporters and editors working full-time for print or broadcast news organizations may register onsite with valid media credentials. All freelancers, college and online publications are strongly encouraged to register in advance by Friday, April 27, 2007.
BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and 31 other nations. BIO members are involved in the research and development of healthcare, agricultural, industrial and environmental biotechnology products.
Upcoming BIO Events
· BIO International Convention
May 6-9, 2007
· BIO VentureForum-East 2007
June 18-20, 2007
· BIO Mid-America Venture Forum 2007
Sep. 24–26, 2007